Showing results (31-40 of 279) with videos related to
Sort By:
Pageof 28
Journal of Cancer Research and Clinical Oncology|January 1, 1983
Phase II trial of aclacinomycin A in acute leukemia and various solid tumorsJ Schütte, N Niederle, S SeeberThe Journal of Infusional Chemotherapy|July 1, 1996
Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatinU Klaassen, H Wilke, S SeeberImmunology Letters|January 31, 1998
Rapamycin antagonizes interleukin-6 mediated growth arrest and differentiation of myeloblastic M1 cellsO Kloke, G Kummer, S SeeberGene|September 28, 1990
Cloning, expression and characterization of the Sau3AI restriction and modification genes in Staphylococcus carnosus TM300S Seeber, C Kessler, F GötzBone Marrow Transplantation|May 30, 2003
Outcome of 67 patients with solid tumors relapsed after high-dose chemotherapy and peripheral blood stem cell transplantationP Bojko, A Akca, S SeeberStrahlentherapie|October 1, 1981
[On the problem of radiotherapeutic measures in addition to chemotherapeutic treatment of the microcellular bronchial carcinoma: analysis of recurrence rates (author's transl)]U Schulz, N Niederle, S SeeberSupportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1994
Complications of spinal opioid therapy: myoclonus, spastic muscle tone and spinal jerkingM Kloke, U Bingel, S SeeberCancer Chemotherapy and Pharmacology|January 1, 1986
Comparative activity of ifosfamide and cyclophosphamideW Brade, S Seeber, K HerdrichAnnals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumorsK Mross, H Richly, N Schleucher, et al.Onkologie|June 1, 1990
[Alpha 2-interferon in kidney cancer. Experiences with 6 patients]B Weidmann, W Hoffmann, S SeeberPageof 28